Draft:Eucalyptus (healthcare company)

Eucalyptus is a healthcare company, consisting of brands Juniper, Pilot, Software, Compound and Kin, offering direct-to-consumer products and telehealth services.

Eucalyptus was founded in 2019 by Tim Doyle, Benny Kleist, Charlie Gearside and Alexey Mitko in Sydney, Australia.

History
Pilot was the first brand launched under Eucalyptus in 2019. Eucalyptus has since launched Kin, Software, Juniper and Compound in Australia, while also expanding Juniper into the UK, Germany and Japan.

In June 2023, Eucalyptus purchased the digital assets of Jenny Craig Australia after the brand fell into voluntary administration.

Pilot
Pilot is an Australian healthcare company for men, providing prescription treatments for hair loss, erectile dysfunction, premature ejaculation and weight management, which are delivered via telehealth.

Kin Fertility
Kin Fertility is an Australian women’s reproductive health brand that sells products for prenatal, pregnancy, postpartum and general health.

Software
Software is an Australian teledermatology company that offers prescription treatments and over-the-counter solutions for acne, ageing and pigmentation.

Juniper
Juniper is a women’s health company specialising in weight loss, using prescription treatments and behavioural change. Juniper currently services patients in Australia, the UK, Germany and Japan.

Compound
Compound is an Australian men’s health brand focused on performance health and longevity.

Fundraising
Eucalyptus raised AUD $8 million in its Series A fundraising in May 2020, which included investors Woolworths Group (Australia), through its venture capital arm W23, and venture capital firm, Blackbird Ventures.

The company raised AUD $30 million in Series B fundraising in July 2021 and $60 million in Series C in January 2022. Another fundraising round in 2023 saw the company land AUD $50 million, mostly from previous investors Blackbird, BOND Capital and W23.

In April 2023, the company was valued at $560 million.